Alzheimer'
Conditions
Interventions
None listed
Sponsors
Department of Neuropsychiatry, Kagawa University School of Medicine
Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe, Japan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Alzheimer's Disease Dementia patients and patients with cognitive concern without Dementia 2) Written Informed consent by each subject and/or a legal representative, and study informant. If the doctor decides that the patient has no trouble in understanding this study, the written informed consent of a legal representative may be exempted. If not, this study needs a written informed consent by a legal representative and the patient except the case where the consent is hardly obtained due to the progression of the disease.
Exclusion criteria
Exclusion criteria: 1) patients with other types of dementia (e.g., vascular dementia, Levy body dementia, frontotemporal dementia) 2) patients with other diseases which cause secondary dementia before Alzheimer's Disease Dementia 3) patients with other severe neurological disease or psychiatric disorder without Alzheimer's Disease Dementia 4) patients with other medical conditions where the investigators determine that it be inappropriate for the subject of this study (e.g., inappropriate for the evaluation of dementia rating scale)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference of three-dimensional distance of the ABC dementia scale between baseline and 12th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Domain scores and total scores of the ABC dementia scale FAST HDS-R Three items of the ABC dementia scale selected by the doctor in charge who expects the improvement of the conditions described in the items. | — |
Countries
Japan
Contacts
Public ContactYu Nakamura
Kagawa University School of Medicine Department of Neuropsychiatry
Outcome results
None listed